Literature DB >> 22994960

Iron oxide-based nanostructures for MRI and magnetic hyperthermia.

Ingrid Hilger1, Werner A Kaiser.   

Abstract

Many different nanostructures have been developed for biomedical applications to date. Among them, iron oxide nanoparticles have been very prominent in MRI in diagnostic radiology. Nowadays, nanoparticle-based therapeutic applications have gained increased interest, leading to the development of a great variety of different and, in parts, sophisticated nanoparticle formulations. Whereas nanotherapy has been confined to the preclinical phase, magnetic hyperthermia has entered into the clinical phase via controlled studies in patients. Owing to the versatility of nanoparticles, researchers envision the combination of multiple modalities (e.g., targeting, diagnostics and therapy) to one carrier. Nevertheless, such approaches have been challenging due to the necessity of the adaptation of at least partially counteracting parameters between the different modalities, which will be analyzed in this review.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994960     DOI: 10.2217/nnm.12.112

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  29 in total

Review 1.  Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.

Authors:  Lei Zhu; Zhiyang Zhou; Hui Mao; Lily Yang
Journal:  Nanomedicine (Lond)       Date:  2016-11-23       Impact factor: 5.307

Review 2.  Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.

Authors:  Marzia Marciello; Juan Pellico; Irene Fernandez-Barahona; Fernando Herranz; Jesus Ruiz-Cabello; Marco Filice
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

3.  Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect.

Authors:  Jing Huang; Liya Wang; Xiaodong Zhong; Yuancheng Li; Lily Yang; Hui Mao
Journal:  J Mater Chem B       Date:  2014       Impact factor: 6.331

Review 4.  Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.

Authors:  Rohun U Palekar; Andrew P Jallouk; Gregory M Lanza; Hua Pan; Samuel A Wickline
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

Review 5.  Hybrid nanoparticles for combination therapy of cancer.

Authors:  Chunbai He; Jianqin Lu; Wenbin Lin
Journal:  J Control Release       Date:  2015-09-24       Impact factor: 9.776

Review 6.  Magnetic Nanoparticles in Cancer Theranostics.

Authors:  Oliviero L Gobbo; Kristine Sjaastad; Marek W Radomski; Yuri Volkov; Adriele Prina-Mello
Journal:  Theranostics       Date:  2015-09-01       Impact factor: 11.556

7.  In vivo murine breast cancer targeting by magnetic iron nanoparticles involving L. GG cytoplasmic fraction.

Authors:  Salar Mokriani; Amir Tukmechi; Naser Harzandi; Leila Jabalameli
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

8.  Effects of Fe3O4 Magnetic Nanoparticles on A549 Cells.

Authors:  Masatoshi Watanabe; Misao Yoneda; Ayaka Morohashi; Yasuki Hori; Daiki Okamoto; Akiko Sato; Daisuke Kurioka; Tadashi Nittami; Yoshifumi Hirokawa; Taizo Shiraishi; Kazuaki Kawai; Hiroshi Kasai; Yukari Totsuka
Journal:  Int J Mol Sci       Date:  2013-07-25       Impact factor: 5.923

9.  Long-term Pulmonary Responses to Quadweekly Intermittent Intratracheal Spray Instillations of Magnetite (Fe3O4) Nanoparticles for 52 Weeks in Fischer 344 Rats.

Authors:  Yukie Tada; Norio Yano; Hiroshi Takahashi; Katsuhiro Yuzawa; Hiroshi Ando; Yoshikazu Kubo; Akemichi Nagasawa; Akiko Inomata; Akio Ogata; Dai Nakae
Journal:  J Toxicol Pathol       Date:  2013-12-26       Impact factor: 1.628

10.  A review of therapeutic aptamer conjugates with emphasis on new approaches.

Authors:  John G Bruno
Journal:  Pharmaceuticals (Basel)       Date:  2013-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.